Novartis Contract Manufacturing

 

Marusa Bozic, Associate Director, Business Development CDMO

April 15 | 2:30pm | Salone dei Cavalieri, Section 2

Basel, Switzerland

(NYSE: NVS)

Novartis Contract Manufacturing is a global contract manufacturing player in the biotech field, Small Molecules and Cell & Gene therapy offering world class manufacturing services in the Novartis state of art facilities across USA, Europe and Asia. We are committed to the highest quality standards. We offer a fully integrated set of Contract Manufacturing Services and Solutions in various fields. Our capabilities are:

Microbial manufacturing: up to 13.000L scale

Mammalian manufacturing: up to 13.000L scale

Cell & Gene Therapy: Viral vector – adherent up to 500 m2, suspension up to 500L; Autologous cell therapy

Plasmid DNA: Small and large scale up to 1.300L

mRNA: Production at 150L scale (larger scales to be discussed)

siRNA & Antisense Oligonucleotides

Fill &Finish: Dropper bottles, Tubes, Low level siliconized Syringes, Vials (liquid, lyophilized)

www.novartis.com/about/manufacturing/contract-manufacturing



By using this website you agree to accept our Privacy Policy and Terms & Conditions